• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Election 2025
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Election 2025
  • Government Shutdown
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Mergers and Acquisitions

    Tag: Mergers and Acquisitions

    An exterior view of the Two Kingdom Street building which houses the headquarters of AstraZeneca, in the Paddington area of London, Friday, May 2, 2014.  The board of pharmaceutical company AstraZeneca on Friday rejected drug maker Pfizer's sweetened takeover offer. Pfizer earlier in the day said it is offering 50 pounds ($84) a share in cash and stock, a 7.3 increase on a previous bid. The offer values AstraZeneca at $106 billion. (AP Photo/Matt Dunham)
    Business

    AstraZeneca rejects sweetened Pfizer takeover bid

    DANICA KIRKALINDA A. JOHNSON -
    May 2, 2014 9:34 pm
    0
    Berkshire Hathaway unit buying AltaLink for $2.92B
    Business

    Berkshire Hathaway unit buying AltaLink for $2.92B

    The Associated Press -
    May 2, 2014 12:00 pm
    0
    Rockville, United banks complete merger
    Business

    Rockville, United banks complete merger

    Washington Examiner -
    May 2, 2014 11:02 am
    0
    AstraZeneca board rejects sweetened takeover offer from Pfizer
    Business

    AstraZeneca board rejects sweetened takeover offer from Pfizer

    Washington Examiner -
    May 2, 2014 9:56 am
    0
    Comcast, Charter to divvy up nation’s cable subs
    Business

    Comcast, Charter to divvy up nation’s cable subs

    Ryan Nakashima -
    April 28, 2014 10:38 pm
    0
    Pfizer still pursuing AstraZeneca after 2nd rebuff
    Business

    Pfizer still pursuing AstraZeneca after 2nd rebuff

    DANICA KIRKALINDA A. JOHNSON -
    April 28, 2014 6:59 pm
    0
    Charter to buy Time Warner cable subscribers
    Business

    Charter to buy Time Warner cable subscribers

    Washington Examiner -
    April 28, 2014 6:22 pm
    0
    Meda rejects revised offer from Mylan
    Business

    Meda rejects revised offer from Mylan

    The Associated Press -
    April 28, 2014 11:00 am
    0
    Prestige to buy Insight Pharma for about $750M
    Business

    Prestige to buy Insight Pharma for about $750M

    Washington Examiner -
    April 25, 2014 12:01 pm
    0
    Zimmer buying Biomet in deal valued at $13.35B
    Business

    Zimmer buying Biomet in deal valued at $13.35B

    Washington Examiner -
    April 24, 2014 1:50 pm
    0
    1...303132...35Page 31 of 35
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter